Geode Capital Management’s Boundless Bio BOLD Stock Holding History

Geode Capital Management’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$140K	Buy	127,576 +33,478	+36%	+$39.2K	﹤0.01%	4034
2025 Q4	$113K	Sell	94,098 -8,170	-8%	-$10.2K	﹤0.01%	4068
2025 Q3	$126K	Buy	102,268 +43,365	+74%	+$50.1K	﹤0.01%	4070
2025 Q2	$59.5K	Sell	58,903 -188,240	-76%	-$250K	﹤0.01%	4179
2025 Q1	$373K	Buy	247,143 +11,284	+5%	+$23.4K	﹤0.01%	3648
2024 Q4	$684K	Buy	235,859 +119,232	+102%	+$347K	﹤0.01%	3502
2024 Q3	$405K	Buy	116,627 +5,993	+5%	+$21.7K	﹤0.01%	3677
2024 Q2	$428K	Buy	+110,634	New	+$1.06M	﹤0.01%	3623

Other funds holding BOLD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Geode Capital Management's BOLD Position: Q1 2026 in Review

Geode Capital Management increased its Boundless Bio (BOLD) stake by 36% in Q1 2026, buying an estimated $39.2K and bringing the position to 127,576 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #4034.

Geode Capital Management first reported a position in BOLD in Q2 2024 and has held it in 8 quarters since. The position peaked at $684K in Q4 2024. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

Geode Capital Management held 127,576 shares of Boundless Bio worth $140K as of Q1 2026.
Geode Capital Management bought 33,478 Boundless Bio shares in Q1 2026, an estimated $39.2K.
Boundless Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4034 holding.
Geode Capital Management first reported a position in Boundless Bio in Q2 2024 and has held it in 8 quarters since.
Geode Capital Management's Boundless Bio position peaked at $684K in Q4 2024.
36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.